Study to Determine the Effects of Fermented Milk Drink on activated CD4+ T cells in Peripheral Blood Mononuclear Cells.
- Conditions
- Male/Female adults
- Registration Number
- JPRN-UMIN000053525
- Lead Sponsor
- Yakult Honsha Co., Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 10
Not provided
1. Subjects who experience abdominal symptoms (such as diarrhea, abdominal pain, bloating) upon consumption of dairy products. 2. Subjects who regularly use Food for Specified Health Uses (FOSHU), Foods with Function Claims, or health food (including supplements) more than twice a week, which may potentially affect the study and cannot discontinue them from the time of consent acquisition. 3. Subjects who are taking medications (such as antibiotics, Intestinal preparations, laxatives) more than twice a week, which may potentially affect the trial, and cannot restrict their use during the study period. 4. Subjects who excessive alcohol intake. 5. Subjects who smoke heavily (not less than 21 cigarettes a day) 6. Females who are pregnant or lactating, and females who could become pregnant or lactating during test period.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Expression of activation markers on activated CD4+ T cells
- Secondary Outcome Measures
Name Time Method 1. Immune cell composition of Peripheral Blood Mononuclear Cells. 2. Immune-related markers in plasma. 3. Immune-related markers in feces. 4. Metabolites in feces. 5. Background questionnaire on daily life 6. Daily questionnaire on test drink and health condition.